Nanomedical Drug Delivery for Neurodegenerative Diseases opens the door for promising approaches and advances in the diagnosis and treatment of various neurodegenerative diseases. The contents of the book comprise all the aspects related to the design, synthesis, and application of different nanodrug delivery systems in the treatment of neurodegenerative disorders, such as Parkinson's disease, Alzheimer's disease, Huntington's disease, and motor neuron diseases. This book explores how nanoparticulate drug carriers can improve therapeutic efficacy by selecting a suitable design strategy. Nanomedical Drug Delivery for Neurodegenerative Diseases is a valuable resource for graduates, clinical researchers, and other scientists working to minimize the challenges to deliver the drugs and genes in a more efficient and targeted manner for the treatment of neurodegenerative diseases.
1. Nanomedical Drug Delivery for Neurodegenerative Diseases - p. Page i 2. Cover - p. Page i 3. Front Matter - p. Page ii 4. Table of Contents - p. Page iii 5. Copyright - p. Page iv 6. Contributors - p. Page iv 7. List of Illustrations - p. Page vi 8. List of Tables - p. Page vii 9. Chapter 1 : Aetiology and pathophysiology of neurodegenerative disorders - p. Page vii 10. Chapter 2 : Current treads of targeted nanoparticulate carriers for the treatment of Alzheimer’s disease - p. Page 12 11. Chapter 3 : Neurodegenerative disorders due to inhalation of various small particles - p. Page 35 12. Chapter 4 : Lipid nanocarrier-based drug delivery for the treatment of brain-related disorders - p. Page 52 13. Chapter 5 : Nanomedical drug delivery for neurodegenerative disease - p. Page 63 14. Chapter 6 : siRNA polymer conjugates for the delivery of RNAi therapeutics for the treatment of Parkinson’s disease - p. Page 76 15. Chapter 7 : Potential of nanoparticles as novel therapeutics against Alzheimer’s disease - p. Page 95 16. Chapter 8 : Recent trends of extracellular vesicles for therapeutic intervention of brain-related diseases - p. Page 113 17. Chapter 9 : Mitochondria-targeted drug delivery systems for the effective treatment of neurodegenerative disorders - p. Page 125 18. Chapter 10 : Recent trends of theranostic applications of nanoparticles in neurodegenerative disorders - p. Page 141 19. Chapter 11 : Role of nanoparticles in neurotoxicity - p. Page 163 20. Chapter 12 : Metal nanoparticles for neurodegenerative diseases - p. Page 179 21. Chapter 13 : Nano-based phytodrug delivery systems for the management of neurodegenerative disorders - p. Page 202 22. Chapter 14 : Nanoparticle-mediated delivery of AChE inhibitors for the treatment of Alzheimer’s disease - p. Page 219 23. Chapter 15 : Nanomaterial-based drug delivery systems as tools for targeted therapy of neurodegenerative diseases - p. Page 237 24. Chapter 16 : Sample preparation techniques for quantitative analysis in brain pharmacokinetics: Application to neurodegenerative diseases - p. Page 256 25. Index - p. Page 265
Nanomedical Drug Delivery for Neurodegenerative Diseases opens the door for promising approaches and advances in the diagnosis and treatment of various neurodegenerative diseases. The contents of the book comprise all the aspects related to the design, synthesis, and application of different nanodrug delivery systems in the treatment of neurodegenerative disorders, such as Parkinson's disease, Alzheimer's disease, Huntington's disease, and motor neuron diseases. This book explores how nanoparticulate drug carriers can improve therapeutic efficacy by selecting a suitable design strategy. Nanomedical Drug Delivery for Neurodegenerative Diseases is a valuable resource for graduates, clinical researchers, and other scientists working to minimize the challenges to deliver the drugs and genes in a more efficient and targeted manner for the treatment of neurodegenerative diseases.
1. Nanomedical Drug Delivery for Neurodegenerative Diseases - p. Page i 2. Cover - p. Page i 3. Front Matter - p. Page ii 4. Table of Contents - p. Page iii 5. Copyright - p. Page iv 6. Contributors - p. Page iv 7. List of Illustrations - p. Page vi 8. List of Tables - p. Page vii 9. Chapter 1 : Aetiology and pathophysiology of neurodegenerative disorders - p. Page vii 10. Chapter 2 : Current treads of targeted nanoparticulate carriers for the treatment of Alzheimer’s disease - p. Page 12 11. Chapter 3 : Neurodegenerative disorders due to inhalation of various small particles - p. Page 35 12. Chapter 4 : Lipid nanocarrier-based drug delivery for the treatment of brain-related disorders - p. Page 52 13. Chapter 5 : Nanomedical drug delivery for neurodegenerative disease - p. Page 63 14. Chapter 6 : siRNA polymer conjugates for the delivery of RNAi therapeutics for the treatment of Parkinson’s disease - p. Page 76 15. Chapter 7 : Potential of nanoparticles as novel therapeutics against Alzheimer’s disease - p. Page 95 16. Chapter 8 : Recent trends of extracellular vesicles for therapeutic intervention of brain-related diseases - p. Page 113 17. Chapter 9 : Mitochondria-targeted drug delivery systems for the effective treatment of neurodegenerative disorders - p. Page 125 18. Chapter 10 : Recent trends of theranostic applications of nanoparticles in neurodegenerative disorders - p. Page 141 19. Chapter 11 : Role of nanoparticles in neurotoxicity - p. Page 163 20. Chapter 12 : Metal nanoparticles for neurodegenerative diseases - p. Page 179 21. Chapter 13 : Nano-based phytodrug delivery systems for the management of neurodegenerative disorders - p. Page 202 22. Chapter 14 : Nanoparticle-mediated delivery of AChE inhibitors for the treatment of Alzheimer’s disease - p. Page 219 23. Chapter 15 : Nanomaterial-based drug delivery systems as tools for targeted therapy of neurodegenerative diseases - p. Page 237 24. Chapter 16 : Sample preparation techniques for quantitative analysis in brain pharmacokinetics: Application to neurodegenerative diseases - p. Page 256 25. Index - p. Page 265
